BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16549262)

  • 1. Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries.
    Abrahamowicz M; Bartlett G; Tamblyn R; du Berger R
    J Clin Epidemiol; 2006 Apr; 59(4):393-403. PubMed ID: 16549262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users.
    Tamblyn R; Abrahamowicz M; du Berger R; McLeod P; Bartlett G
    J Am Geriatr Soc; 2005 Feb; 53(2):233-41. PubMed ID: 15673346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly.
    Sylvestre MP; Abrahamowicz M; Čapek R; Tamblyn R
    Int Psychogeriatr; 2012 Apr; 24(4):577-86. PubMed ID: 22059800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical uses and advantages of low doses of benzodiazepine hypnotics.
    Vogel G
    J Clin Psychiatry; 1992 Jun; 53 Suppl():19-22. PubMed ID: 1613015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life.
    Herings RM; Stricker BH; de Boer A; Bakker A; Sturmans F
    Arch Intern Med; 1995 Sep; 155(16):1801-7. PubMed ID: 7654115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexible modeling of the cumulative effects of time-dependent exposures on the hazard.
    Sylvestre MP; Abrahamowicz M
    Stat Med; 2009 Nov; 28(27):3437-53. PubMed ID: 19708037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries.
    Ray WA; Thapa PB; Gideon P
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):663-9. PubMed ID: 12512242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of alternative models for linking drug exposure with adverse effects.
    Abrahamowicz M; Beauchamp ME; Sylvestre MP
    Stat Med; 2012 May; 31(11-12):1014-30. PubMed ID: 22095719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of hypnotics.
    Rickels K
    J Clin Psychopharmacol; 1983 Apr; 3(2):133-9. PubMed ID: 6132932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual effects of temazepam and other hypnotic compounds on cognitive function.
    Pishkin V; Lovallo WR; Fishkin SM; Shurley JT
    J Clin Psychiatry; 1980 Oct; 41(10):358-63. PubMed ID: 6107292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pharmacokinetics of 5 hypnotic benzodiazepines in healthy volunteers].
    Jochemsen R; Van Boxtel CJ; Breimer DD
    Nouv Presse Med; 1982 Oct; 11(40):2965-6. PubMed ID: 6128720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan.
    Cheng JS; Huang WF; Lin KM; Shih YT
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):618-24. PubMed ID: 18058834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice.
    Gorgels WJ; Oude Voshaar RC; Mol AJ; van de Lisdonk EH; van Balkom AJ; Breteler MH; van den Hoogen HJ; Mulder J; Zitman FG
    Fam Pract; 2006 Feb; 23(1):65-72. PubMed ID: 16107495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application.
    Stewart R; Niessen WJ; Broer J; Snijders TA; Haaijer-Ruskamp FM; Meyboom-De Jong B
    J Clin Epidemiol; 2007 Oct; 60(10):1076-84. PubMed ID: 17884604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytics and sedatives and risk of fractures: effects of half-life.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Jan; 82(1):34-43. PubMed ID: 18175030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal after substitution of a short-acting for a long-acting benzodiazepine.
    Conell LJ; Berlin RM
    JAMA; 1983 Nov; 250(20):2838-40. PubMed ID: 6139491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of three benzodiazepine hypnotics as oral pre-anaesthetic medication.
    Hare SA
    S Afr Med J; 1975 Oct; 49(45):1883-4. PubMed ID: 1103330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk of falling due to benzodiazepine administration, alone or in combination, in elderly subjects].
    Tillement JP; Albengres E; Cottin D; Klouz A; Arkoub H; Le Louet H
    Therapie; 2001; 56(4):435-40. PubMed ID: 11677869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of benzodiazepines on posaconazole serum concentrations. A population-based pharmacokinetic study on drug interaction.
    Heinz WJ; Grau A; Ulrich A; Helle-Beyersdorf A; Zirkel J; Schirmer D; Lenker U; Einsele H; Klinker H
    Curr Med Res Opin; 2012 Apr; 28(4):551-7. PubMed ID: 22303909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.